Cargando…
A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophy...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308850/ https://www.ncbi.nlm.nih.gov/pubmed/25609176 http://dx.doi.org/10.1186/s12876-014-0226-6 |
_version_ | 1782354596632461312 |
---|---|
author | Takahashi, Hiroaki Arimura, Yoshiaki Okahara, Satoshi Kodaira, Junichi Hokari, Kaku Tsukagoshi, Hiroyuki Shinomura, Yasuhisa Hosokawa, Masao |
author_facet | Takahashi, Hiroaki Arimura, Yoshiaki Okahara, Satoshi Kodaira, Junichi Hokari, Kaku Tsukagoshi, Hiroyuki Shinomura, Yasuhisa Hosokawa, Masao |
author_sort | Takahashi, Hiroaki |
collection | PubMed |
description | BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophylactic treatment for esophageal stenoses following extensive ESD. This single center trial was conducted at the Keiyukai Hospital, a tertiary care center for gastrointestinal disease in Japan [University Hospital Medical Network Clinical Trial Registry (UMIN-CTR) on 15 September 2011 (UMIN000006327)]. Thirty-two patients with mucosal defects involving ≥75% of the esophageal circumference were randomized to receive a single dose of triamcinolone acetonide injections (n = 16) or be treated conventionally (n = 16). The primary outcome was the frequency of stricture requiring endoscopic dilatation; the surrogate primary endpoint was the number of dilatation sessions needed. Secondary outcomes included adverse event rates, the minimum diameter of the stenotic area and the duration of the course of dilatation treatments. RESULTS: The frequency of stricture was not significantly different between the groups because of insufficient statistical power, but the number of dilatation sessions required was significantly less in the steroid group (6.1 sessions [95% confidence interval, CI 2.8–9.4] versus 12.5 [95% CI 7.1–17.9] sessions in the control group; P = 0.04). The perforation rate was similar in both groups. The minimum diameter of stenotic lumens was significantly greater in the treatment group than controls (11.0 mm versus 7.1 mm, respectively; P = 0.01). The perforation rate was not significantly different between the groups (1.0% versus 0.5% in the treatment and control group, respectively). Steroid injection was effective in cases of mucosal defects encompassing the entire esophageal circumference. CONCLUSIONS: Prophylactic endoscopic steroid injection appears to be a safe means of relieving the severity of esophageal stenoses following extensive ESD. |
format | Online Article Text |
id | pubmed-4308850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43088502015-01-29 A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection Takahashi, Hiroaki Arimura, Yoshiaki Okahara, Satoshi Kodaira, Junichi Hokari, Kaku Tsukagoshi, Hiroyuki Shinomura, Yasuhisa Hosokawa, Masao BMC Gastroenterol Research Article BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophylactic treatment for esophageal stenoses following extensive ESD. This single center trial was conducted at the Keiyukai Hospital, a tertiary care center for gastrointestinal disease in Japan [University Hospital Medical Network Clinical Trial Registry (UMIN-CTR) on 15 September 2011 (UMIN000006327)]. Thirty-two patients with mucosal defects involving ≥75% of the esophageal circumference were randomized to receive a single dose of triamcinolone acetonide injections (n = 16) or be treated conventionally (n = 16). The primary outcome was the frequency of stricture requiring endoscopic dilatation; the surrogate primary endpoint was the number of dilatation sessions needed. Secondary outcomes included adverse event rates, the minimum diameter of the stenotic area and the duration of the course of dilatation treatments. RESULTS: The frequency of stricture was not significantly different between the groups because of insufficient statistical power, but the number of dilatation sessions required was significantly less in the steroid group (6.1 sessions [95% confidence interval, CI 2.8–9.4] versus 12.5 [95% CI 7.1–17.9] sessions in the control group; P = 0.04). The perforation rate was similar in both groups. The minimum diameter of stenotic lumens was significantly greater in the treatment group than controls (11.0 mm versus 7.1 mm, respectively; P = 0.01). The perforation rate was not significantly different between the groups (1.0% versus 0.5% in the treatment and control group, respectively). Steroid injection was effective in cases of mucosal defects encompassing the entire esophageal circumference. CONCLUSIONS: Prophylactic endoscopic steroid injection appears to be a safe means of relieving the severity of esophageal stenoses following extensive ESD. BioMed Central 2015-01-22 /pmc/articles/PMC4308850/ /pubmed/25609176 http://dx.doi.org/10.1186/s12876-014-0226-6 Text en © Takahashi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Takahashi, Hiroaki Arimura, Yoshiaki Okahara, Satoshi Kodaira, Junichi Hokari, Kaku Tsukagoshi, Hiroyuki Shinomura, Yasuhisa Hosokawa, Masao A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title | A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title_full | A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title_fullStr | A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title_full_unstemmed | A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title_short | A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
title_sort | randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308850/ https://www.ncbi.nlm.nih.gov/pubmed/25609176 http://dx.doi.org/10.1186/s12876-014-0226-6 |
work_keys_str_mv | AT takahashihiroaki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT arimurayoshiaki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT okaharasatoshi arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT kodairajunichi arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT hokarikaku arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT tsukagoshihiroyuki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT shinomurayasuhisa arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT hosokawamasao arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT takahashihiroaki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT arimurayoshiaki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT okaharasatoshi randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT kodairajunichi randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT hokarikaku randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT tsukagoshihiroyuki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT shinomurayasuhisa randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection AT hosokawamasao randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection |